| Item | Cat. No. | Type | Clone No |
| Anti-VEGFA mAbs [Tarcocimab Biosimilar] (MABL-5287) | MABL-5287 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-NOTCH2 and NOTCH3 mAbs [Tarextumab Biosimilar] (MABL-5288) | MABL-5288 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-DLL3;CD3E mAbs [Tarlatamab Biosimilar] (MABL-5289) | MABL-5289 | ELISA, FACS, Functional assay, in vivo binding | na;na, Kappa;Lambda |
| Anti-ALB;CFP mAbs [Tarperprumig Biosimilar] (MABL-5290) | MABL-5290 | ELISA, FACS, Functional assay, in vivo binding | na;na, na;na |
| Anti-TNFSF4/CD134/CD252/OX40L mAbs [Tavolimab Biosimilar] (MABL-5291) | MABL-5291 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CTLA4/CD152 mAbs [Tazlestobart Biosimilar] (MABL-5292) | MABL-5292 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD3E mAbs [Tebentafusp Biosimilar] (MABL-5293) | MABL-5293 | ELISA, FACS, Functional assay, in vivo binding | na, Kappa |
| Anti-Respiratory Syncytial Virus Glycoprotein F mAbs [Suptavumab Biosimilar] (MABL-5262) | MABL-5262 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD3D&CD3E;CD19 mAbs [Surovatamig Biosimilar] (MABL-5263) | MABL-5263 | ELISA, FACS, Functional assay, in vivo binding | G4;G4, Kappa;na |
| Anti-HAVCR2/TIM3 mAbs [Surzebiclimab Biosimilar] (MABL-5264) | MABL-5264 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-F7a/F7A/FVIIa/FVIIA;TREML1/GLTL1825/PRO3438/TLT-1/TLT1 mAbs [Sutacimig Biosimilar] (MABL-5265) | MABL-5265 | ELISA, FACS, Functional assay, in vivo binding | G4;G4, Kappa;Kappa |
| Anti-C1S mAbs [Sutimlimab Biosimilar] (MABL-5266) | MABL-5266 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-VEGFA mAbs [Suvemcitug Biosimilar] (MABL-5267) | MABL-5267 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-HIV-1 gp120 mAbs [Suvizumab Biosimilar] (MABL-5268) | MABL-5268 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD24 mAbs [Suvonstobart Biosimilar] (MABL-5269) | MABL-5269 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Staphylococcus aureus Toxin A mAbs [Suvratoxumab Biosimilar] (MABL-5270) | MABL-5270 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFSF13B/CD257/BAFF mAbs [Tabalumab Biosimilar] (MABL-5271) | MABL-5271 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IL6 mAbs [Tabirafusp Biosimilar] (MABL-5272) | MABL-5272 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-FZD10/CD350 mAbs [Tabituximab Biosimilar] (MABL-5273) | MABL-5273 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Alpha Ferroprotein mAbs [Tacatuzumab Biosimilar] (MABL-5274) | MABL-5274 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
